Skip to main content

This job has expired

You will need to login before you can apply for a job.

Executive / Senior Director, Core Team Leader, Gene Therapy for Hemophilia A

Employer
BioMarin Pharmaceutical Inc.
Location
San Rafael, California
Start date
Jul 28, 2021

View more

Discipline
Science/R&D, Biotherapeutics, Genetics
Required Education
Bachelors Degree
Position Type
Full time
Hotbed
Biotech Bay, Best Places to Work

Job Details

BioMarin is the world leader in delivering therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We target diseases that lack effective therapies and affect relatively small numbers of patients, many of whom are children. These conditions are often inherited, difficult to diagnose, progressively debilitating and have few, if any, treatment options. BioMarin will continue to focus on advancing therapies that are the first or best of their kind.

By providing a foundation for all operations company wide, BioMarin’s General and Administrative teams support our mission of providing first and best in class therapeutics to patients who live with rare diseases. Our teams include groups such as finance, legal, human resources, corporate compliance and ethics, and information technology. Come join our team and make a meaningful impact on patients’ lives.



BioMarin’s Product Portfolio Development (PPD) is responsible for BioMarin’s corporate and R&D governance, business operating model (core teams and sub-teams)Competitive Intelligence, Global Patient Advocacy and Engagement  and portfolio strategy. PPD integrates overall product strategy and ensures planning and timely execution to inform decision making and development of therapies and life cycle strategies at BioMarin.

Program & Position Impact:

At BioMarin we work for hope.  Our Gene Therapy for Hemophilia A Program embodies this statement.  BioMarin is developing gene therapy via an AAV-factor VIII vector, valoctocogene roxaparvovec, an investigational drug for the treatment of Hemophilia A.

This is an opportunity to champion this transformative gene therapy through approval, launch and lead lifecycle efforts.  BMRN has a strong pipeline of gene therapy assets focused on populations with significant unmet need and you will have the opportunity to potentially lead a global launch of this transformative medicine.

About the Team:

The Core Team Leader Group is part of BioMarin’s Corporate Product Portfolio Development function which reports to the Chief Scientific Strategy Officer.  Product Portfolio Development is responsible for BioMarin’s corporate and product governance, business operating model (core teams and partner teams), portfolio strategy and business financial planning, strategic business insights and Competitive Intelligence.

Core Team Leader (CTL) Position:

CTL is the product champion and leads a team of functional leaders that together develop product strategy which is reviewed and approved by BioMarin governance.  CTL is the primary liaison with executive management and has overall accountability to executive management for the integrated product strategy. In collaboration with core team (CT) members, the CTL ensures progress and execution against plans and as the leader of the CT is the primary contact for internal stakeholders. As a senior leader in the core team leader group, is a role model, mentors peers and contributes to key core team processes and initiatives.

Experience:

  • 12+ years experience in the biotechnology/ pharmaceutical industry. Rare disease experience is a plus.
  • 5+ years of experience leading a core/cross functional strategy team for an investigational or marketed therapy or as commercial leader who has both development and launch experience.
  • The successful candidate will also demonstrate strong matrix leadership ability and professional credibility to influence a highly intelligent and sophisticated audience of colleagues, partners, and external constituents.

This individual must be a self-starter and possess excellent leadership, influencing and communication skills, as they will be applied at all levels, including at the core team, interactions with the executive team, and presentations to internal and external audiences.

 General CTL Responsibilities:

  1. Program Strategy
  • Lead the CT in the evolving Target Product Profile for launch  to maximize Valrox’s potential for Hem A patients and for the business
  • Ensure integrated stage-based product plans that are aligned with program strategy and ensures assumptions and drivers are aligned with plans to inform financial planning
  • Establish strong partnerships with all functional stakeholders, specifically Clinical Science, Medical Affairs, Regulatory and Commercial to ensure approval and launch success.
  • Ensure potential risks/trade-offs are identified and contingency planning with a solutions’ focused mindset.
  1. Team Effectiveness
  • Ensure cross functional partnerships and resources are leveraged effectively, and with accountability, to achieve program objectives.
  • Drive collaboration and transparency across all functions on the CT and challenge team members to be broad and inclusive in their strategy planning.
  • Resolve conflicts at the Core Team, provide and receive feedback to develop and maintain a high performing team
  1. Governance and Approvals
    • Ensure that team recommendations are brought to appropriate governance for decision
    • Ensure alignment of program strategy/plan/execution with management expectations & priorities
  2. Communication
    • Single point of contact on program for executive and functional management
    • Ensures communication of rationale and context for decisions made to team
    • Leads team in developing a comprehensive internal and external communication plan with team input for important program milestones, key data, etc.
    • Reviews and agrees to publication plan, reviews publication concepts, presentations and manuscripts
    • Primary source for information as needed for external communications (press releases, investor related, etc.)
    • Reviews health authority related documents and ensures consistency with strategic objectives for the program

Education:

  • The successful candidate will ideally have an advanced degree in a scientific discipline (e.g. Pharm D, Ph.D. or M.D.)
  • BS. is Life Sciences is a plus.

We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity, sexual orientation, national origin, disability status, protected veteran status, or any other characteristic protected by law.

Company

BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. In 1997, the company was founded to make a big difference in small patient populations, focusing on giving much-needed attention to the underserved communities of those with rare diseases. BioMarin sought to help patients whose voices could not always be heard and treat conditions that were not always in mainstream medical conversations. Throughout its history, BioMarin has worked tirelessly to make a difference by pursuing bold science. The company’s first approved therapy was inspired by a father who refused to accept there was no therapy for his son’s rare diagnosis. That relentless pursuit to change the course of his son’s future through the power of science is at the core of who BioMarin is today.

Through the company’s expertise in genetics and molecular biology, BioMarin has developed eight first or best-in-class targeted therapies that address the root cause of the conditions it seeks to treat, helping to better the lives of those struggling with rare genetic disease. The company’s purposeful and scientifically precise team of physicians and scientists has honed each treatment modality to seek transformative therapies.

Now, BioMarin seeks to make an even greater impact by applying the same science-driven, patient-forward approach that propelled the last 25 plus years of drug development to larger genetic disorders, as well as genetic subsets of more common conditions. Each drug candidate pursued is guided by a fundamental understanding of the genetics and underlying biology of the condition it will address. The company believes that applying its knowledge to make a transformative impact is not just a calling, but an obligation to those who will benefit most. The more innovative solutions developed, the more lives BioMarin can impact.

Company info
Website
Location
California
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert